Agastache.

Agastache rugosa, huo xiang in Chinese practice and bangah in Korean, is used as an aromatic herb for digestive discomfort, the same role peppermint occupies in Western herbal practice. Both act largely through volatile constituents on smooth muscle and sensory nerve endings. The overlap is in use case and constituent class, and direct comparative or combination data is not available.

Agastache and ginger appear together in the classical huo xiang zheng qi formulation used for digestive upset with nausea. The pairing is centuries old and consistent across the tradition. It is documented use rather than trial evidence, and should be presented that way.

Licorice appears as the harmonising herb in the same classical formulation that contains agastache, a role it plays across a large share of traditional Chinese prescriptions. Anyone reproducing that pairing should note that glycyrrhizin affects potassium handling and blood pressure with sustained use. Deglycyrrhizinated licorice avoids that issue but changes the traditional material.

Rosmarinic acid is a major phenolic in Agastache rugosa and gives rosemary its name. Two sources of the same compound stack the intake rather than adding distinct chemistry. That matters for anyone tallying total phenolic exposure across a formula.

Lemon balm is another Lamiaceae member rich in rosmarinic acid, so combining it with agastache duplicates the same phenolic. Both are also used as gentle calming herbs. The additive element is compositional, and combination trials do not exist.

Agastache rugosa contains acacetin and tilianin, a flavone and its glycoside that sit in the same structural family as luteolin and apigenin. Gut bacteria hydrolyse tilianin to acacetin before absorption, so the microbiome shapes exposure. Combining sources of the same flavone class raises total intake of closely related molecules.

Flavonoid glycosides from agastache and quercetin compete for the same conjugation and efflux machinery in the enterocyte and liver. That can raise or lower measured plasma levels of either depending on the doses involved. The interaction is documented for flavonoids as a class rather than for this herb specifically.

Ascorbate regenerates oxidised phenolic radicals back to their reduced form in vitro, which is why phenolic extracts and vitamin C are commonly paired. Whether that recycling occurs at meaningful rates in human tissue at supplement doses is much less clear. Antioxidant capacity assays are laboratory markers, not health outcomes.

Piperine inhibits intestinal and hepatic glucuronidation and sulfation, the routes that clear most plant phenolics within minutes of absorption. Adding it raises plasma exposure to flavonoids and phenolic acids from herbs like agastache. The same inhibition applies to prescription medicines cleared by those enzymes, which is why piperine is not a neutral addition.

The essential oil fraction of agastache is lipophilic and disperses poorly in water. A medium-chain triglyceride carrier keeps volatile constituents in solution and stabilises dosing in softgels and liquids. This is a delivery choice, not an effect on activity.

Phospholipid complexation is a standard approach for poorly soluble plant phenolics, improving dispersion and membrane partitioning. It is used across the botanical category rather than being specific to this herb. Whether it changes any measured outcome for agastache constituents has not been tested.